Search Results - "Djalalov, S"

Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in Canada by Djalalov, S, Beca, J, Amir, E, Krahn, M, Trudeau, M E, Hoch, J S

“…Aromatase inhibitor (ai) therapy has been subjected to numerous cost-effectiveness analyses. However, with most ais having reached the end of patent protection…”
Get full text

The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario by Djalalov, S, Graham, D.M, Beca, J, Hoch, J.S, Tsao, M.S, Cutz, J.C, Leighl, N

Get full text

Pilot of three objective markers of physical health and chemotherapy toxicity in older adults by Hsu, T, Chen, R, Lin, S C X, Djalalov, S, Horgan, A, Le, L W, Leighl, N

“…Patient function is a key part of the clinical decision to offer chemotherapy and has, in earlier studies, been associated with chemotherapy toxicity…”
Get full text

The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer by Djalalov, S, Graham, D.M, Beca, J, Hoch, J.S, Tsao, M.S, Leighl, N

Get full text

Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada) by Djalalov, S, Beca, J, Hoch, J.S, Krahn, M.D, Tsao, M.S, Cutz, J.C, Leighl, N

Get full text

42 10 year retrospective review of single agent chemotherapy as first line treatment in advanced non-small cell lung cancer (NSCLC) in Princess Margaret Hospital: Assessment of efficacy and prognostic factors by Martin, P, Metran-Nascente, C, Djalalov, S, Lin, S, Leighl, N.B

Get full text

PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada by Djalalov, S, Beca, J, Li, B, Krahn, M, Hoch, J

Get full text

PCN87 Cost-Effectiveness of Hormone Therapies for ER+ Women with Early Breast Cancer in Canada: Exploring the Potential for the Cyp2D6 Genetic Test by Djalalov, S, Beca, J, Li, B, Krahn, M, Hoch, J.S

Get full text

Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario by Djalalov, S, Hoch, J.S, Beca, J, Krahn, M, Tsao, M.S, Cutz, J.C, Leighl, N

Get full text

PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE? by Djalalov, S, Beca, J, Hoch, J

Get full text

PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients: An Exploratory Economic Evaluation of Personalized Medicine by Djalalov, S, Yong, J, Beca, J, Black, S, Saposnik, G, Musa, Z, Siminovitch, K, Moretti, M, Hoch, J

Get full text

PND55 ECONOMIC EVALUATION OF ENDOSCOPIC THIRD VENTRICULOSTOMY COMPARED TO SHUNTING IN PEDIATRIC PATIENTS WITH HYDROCEPHALUS IN UZBEKISTAN by Djalalov, S., Erkinova, S., Babakhanov, B.

Get full text

PCN60 FITTING DISTRIBUTIONS OF PARAMETRIC MODELS INTO NON-PARAMETRIC KAPLAN-MEIER CURVE: APPLICATION IN EXCEL AND COMPARISON OF DIFFERENT DATA RECREATION METHODS by Djalalov, S., Beca, J., Ewara, E., Hoch, J.S.

Get full text

PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW by Djalalov, S., Djalalova, D., Krahn, M., Matveev, N., Hoch, J.

Get full text

PDB63 COST-EFFECTIVENESS OF INSULIN PUMP AND CONTINUES GLUCOSE MONITORING VERSUS MULTIPLE DAILY INJECTIONS AND SELF-MONITORING OF BLOOD GLUCOSE IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS by Djalalov, S., Reimbaev, T., Nuriddinov, K., Djabriyev, D., Gulyamova, K., Alimova, N.

Get full text

COST-EFFECTIVENESS OF PERCUTANEOUS VENTRICULAR ASSIST DEVICES FOR HIGH-RISK PCI PATIENTS IN ONTARIO, CANADA by Djalalov, S, Xie, X, Wijeysundera, HC, Sikich, N, Dhalla, I, Ng, V

“…OBJECTIVES: The newly introduced percutaneous Ventricular Assist Devices (pVAD) have been shown to provide better hemodynamic support but there is no evidence…”
Get full text

PCN162 - The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer by Djalalov, S., Graham, D.M., Beca, J., Hoch, J.S., Tsao, M.S., Leighl, N.

Get full text

A review of economic evaluations of genetic testing services and interventions (2004–2009) by Djalalov, Sandjar, Musa, Zahra, Mendelson, Michael, Siminovitch, Katherine, Hoch, Jeffrey

“…To review economic evaluations of genetic interventions published between 2004 and 2009 and assess the quality of the identified studies, we searched for…”
Get full text

PCN128 - The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario by Djalalov, S., Graham, D.M., Beca, J., Hoch, J.S., Tsao, M.S., Cutz, J.C., Leighl, N.

Get full text

PCN105 - Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada) by Djalalov, S., Beca, J., Hoch, J.S., Krahn, M.D., Tsao, M.S., Cutz, J.C., Leighl, N.

Get full text